Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	1 Months Ended	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss		$ (2,947,420)	$ (4,073,307)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted		687,752	275,833
Depreciation and amortization		12,326	13,983
Change in fair value of stock-based compensation liability			1,741,919
Changes in operating assets and liabilities:
Prepaid expenses		(474,776)	(325,635)
Research and development tax rebate receivable		5,316	280,242
Other assets		(108,389)	2,985
Accounts payable		63,081	110,642
Accrued expenses		(25,414)	(102,230)
Payroll liabilities		(433,037)	(43,312)
Other current liabilities		(9,434)	(30,076)
Net cash used in operating activities		(3,229,995)	(2,148,956)
CASH FLOWS FROM INVESTING ACTIVITY
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from exercise of warrants	$ 11,300,000	0	11,336,710
Net cash provided by financing activities			11,336,710
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH		(3,229,995)	9,187,754
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE		12,691,136	10,490,493
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	19,678,247	9,461,141	19,678,247
SUPPLEMENTAL DISCLOSURES
Cash and cash equivalents	19,568,247	9,351,141	19,568,247
Restricted cash	110,000	110,000	110,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	$ 19,678,247	9,461,141	19,678,247
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation			$ 3,151,944